Regression of pre-established intracranial tumor growth by ON 01910.Na, a selective anticancer agent currently in phase I trials
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: C. S. Gondi, N. Kandhukuri, N. Yanamandra, M. Reddy, E. Reddy, J. S. Rao
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2545464896
